Cancer Reports Associated with 2018 Recalls of Angiotensin Receptor Blockers
2021
In July 2018, several lots of the angiotensin receptor blocker (ARB) valsartan were recalled worldwide because the potential carcinogen
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI